(Q42250207)

English

Discovery of ledipasvir (GS-5885): a potent, once-daily oral NS5A inhibitor for the treatment of hepatitis C virus infection

scientific article published on 10 January 2014

Statements

Discovery of ledipasvir (GS-5885): a potent, once-daily oral NS5A inhibitor for the treatment of hepatitis C virus infection (English)
John O Link
James G Taylor
Lianhong Xu
Michael Mitchell
Hongyan Guo
Hongtao Liu
Darryl Kato
Thorsten Kirschberg
Jianyu Sun
Neil Squires
Jay Parrish
Terry Keller
Zheng-Yu Yang
Chris Yang
Mike Matles
Yujin Wang
Kelly Wang
Guofeng Cheng
Yang Tian
Erik Mogalian
Elsa Mondou
Melanie Cornpropst
Jason Perry
Manoj C Desai
10 January 2014
2033-2046

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit